Exposure to specific herbal products during pregnancy and the risk of low birth weight

Alternative Therapies in Health and Medicine

Volumn 18, Issue 2, 2012, Pages 36-43

  Moussally, Krystel ^a   Bérard, Anick ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT MEDICINAL PRODUCT;

ADULT; ARTICLE; CANADA; CASE CONTROL STUDY; CHAMAEMELUM; ENVIRONMENTAL EXPOSURE; FEMALE; FLAX; HUMAN; LOW BIRTH WEIGHT; MENTHA PIPERITA; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; QUESTIONNAIRE; REGISTER; RISK FACTOR; SECOND TRIMESTER PREGNANCY; STATISTICS; TEA; THIRD TRIMESTER PREGNANCY;

ADULT; CAMELLIA; CASE-CONTROL STUDIES; CHAMAEMELUM; FEMALE; FLAX; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MATERNAL EXPOSURE; MENTHA PIPERITA; PLANT PREPARATIONS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; QUEBEC; QUESTIONNAIRES; REGISTRIES; RISK FACTORS;

EID: 84861180248     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Woolhouse M. Complementary medicine for pregnancy complications. Aust Fam Physician. 2006;35(9):695.
2. Lapi F, Vannacci A, Moschini M, et al. Use, attitudes and knowledge of complementary and alternative drugs (CADs) among pregnant women: a preliminary survey in Tuscany. Evid Based Complement Alternat Med. 2010;7(4):477-486.
3. Moussally K, Oraichi D, Bérard A. Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Saf. 2009;18(6):454-461.
4. Mabina MH, Pitsoe SB, Moodley J. The effect of traditional herbal medicines on pregnancy outcome. The King Edward VIII Hospital experience. S Afr Med J. 1997;87(8):1008-1010.
5. Ernst E. Herbal medicinal products during pregnancy: are they safe? BJOG. 2002;109(3):227-235.
6. Marcus DM, Snodgrass WR. Do no harm: avoidance of herbal medicines during pregnancy. Obstet Gynecol. 2005;105(5 Part 1):1119-1122.
7. Krystel M, Anick B. Exposure to herbal products during pregnancy and the risk of preterm birth. Eur J Obstet Gynecol Reprod Biol. 2010;150(1):107-108.
8. Marrone CM. Safety issues with herbal products. Ann Pharmacother. 1999;33(12):1359-1362.
9. Johns T, Sibeko L. Pregnancy outcomes in women using herbal therapies. Birth Defects Res B Dev Reprod Toxicol. 2003;68(6):501-504.
10. Canadian Institute for Health Information. Giving Birth in Canada: Regional Trends From 2001-2002 to 2005-2006. Toronto, ON: Canadian Institute for Health Information; 2007.
11. Tou JC, Chen J, Thompson LU. Flaxseed and its lignan precursor, secoisolariciresinol diglycoside, affect pregnancy outcome and reproductive development in rats. J Nutr. 1998;128(11):1861-1868.
12. Boswell-Ruys CL, Ritchie HE, Brown-Woodman PD. Preliminary screening study of reproductive outcomes after exposure to yarrow in the pregnant rat. Birth Defects Res B Dev Reprod Toxicol. 2003;68(5):416-420.
13. World Health Organization. International Classification of Diseases (ICD). Geneva, Switzerland: WHO; 1977.
14. Lacasse A, Berard A. Validation of the nausea and vomiting of pregnancy specific health related quality of life questionnaire. Health Qual Life Outcomes. 2008;6:32.
15. Ofori BD, Le Tiec M, Berard A. Risk factors associated with preterm birth according to gestational age at birth. Pharmacoepidemiol Drug Saf. 2008;17(6):556-564.
16. Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol. 2007;80(1):18-27.
17. Ofori B, Oraichi D, Blais L, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol. 2006;77(4):268-279.
18. Ramos E, Oraichi D, Rey E, Blais L, Bérard A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG. 2007;114(9):1055-1064.
19. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol. 1995;48(8):999-1009.
20. Levy AR, Mayo NE, Grimard G. Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981-1992. Am J Epidemiol. 1995;142(4):428-436.
21. Vilain A, Otis S, Forget A, Blais L. Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiol Drug Saf. 2008;17(4):345-353.
22. Wardlaw T, Blanc A, Zupan J, Åhman E; United Nations Children's Fund and World Health Organization. Low Birthweight: Country, Regional and Global Estimates. New York, NY: UNICEF; 2004.
23. Holst L, Nordeng H, Haavik S. Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome. Pharmacoepidemiol Drug Saf. 2008;17(2):151-159.
24. Gallo M, Sarkar M, Au W, et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med. 2000;160(20):3141-3143.
25. Strandberg TE, Järvenpää AL, Vanhanen H, McKeigue PM. Birth outcome in relation to licorice consumption during pregnancy. Am J Epidemiol. 2001;153(11):1085-1088.
26. Herceg A, Simpson JM, Thompson JF. Risk factors and outcomes associated with low birthweight delivery in the Australian Capital Territory 1989-90. J Paediatr Child Health. 1994;30(4):331-335.
27. Pollack H, Lantz PM, Frohna JG. Maternal smoking and adverse birth outcomes among singletons and twins. Am J Public Health. 2000;90(3):395-400.
28. Bada HS, Das A, Bauer CR, et al. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol. 2005;25(10):631-637.
29. Feresu SA, Harlow SD, Welch K, Gillespie BW. Incidence of and socio-demographic risk factors for stillbirth, preterm birth and low birthweight among Zimbabwean women. Paediatr Perinat Epidemiol. 2004;18(2):154-163.
30. Barros H, Tavares M, Rodrigues T. Role of prenatal care in preterm birth and low birthweight in Portugal. J Public Health Med. 1996;18(3):321-328.
31. No authors listed. Green Tea Extracts. Health Canada. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/monograph/mono_greentea-thevert-eng.php. Accessed March 14, 2012.
32. No authors listed. Green Tea (Camellia sinensis). Natural Standard. http://acphs.naturalstandard. com/index-abstract.asp?create-abstract=patient-green_tea.asp&title=Green%20 tea. Accessed March 14, 2012.
33. Altuncu E, Kavuncuoǧlu S, Gökmirza PO, Albayrak Z, Arduç A. The incidence of low birth weight in 5000 liveborn infants and the etiology of fetal risk factors [article in Turkish]. Marmara Med J. 2006;19(2):46-51.
34. Gardiner P. Complementary, holistic, and integrative medicine: chamomile. Pediatr Rev. 2007;28(4):e16-e18.
35. Troude P, L'Hélias LF, Raison-Boulley AM, et al. Perinatal factors reported by mothers: do they agree with medical records? Eur J Epidemiol. 2008;23(8):557-564.
36. Hassan E. Recall bias can be a threat to retrospective and prospective research designs. Internet J Epidemiol. 2006;3(2). http://www.ispub.com/journal/the-internet-journal-of-epidemiology/volume-3-number-2/recall-bias-can-be-a-threat-to-retrospective-and-prospective-research-designs.html. Accessed January 30, 2012.
37. Lynch N, Berry D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complement Ther Med. 2007;15(2):84-91.